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Notch signaling inhibits hair cell differentiation, based on studies on mice deficient in Notch signaling-related genes and its downstream genes.
However, the precise mechanisms of this inhibition are unknown because it is difficult to control the timing and duration of the suppression of
Notch signaling. Here, we developed a novel in vitro culture and analysis method for mouse fetal cochleae and examined the roles of Notch
signaling by its reversible inhibition through the use of Notch signaling inhibitors of γ-secretase and TNF-alpha-converting enzyme. Notch
inhibition with Notch signaling inhibitor treatment increases the number of cochlear hair cells, as observed in gene deletion experiments. We
elucidated that this increase is regulated by the dichotomy between hair cells and supporting cells from common progenitors. We also propose
other roles of Notch signaling in cochlear development. First, Notch signaling arrests the cell cycle of the cochlear epithelium containing putative
hair cells and supporting cell progenitors because Notch inhibition with inhibitor treatment increases the number of 5-bromo-2′-deoxyuridine
(BrdU)-positive cells that can differentiate into hair cells or supporting cells. Second, Notch signaling is required for the induction of Prox1-
positive supporting cells. Third, Notch signaling is required for the maintenance of supporting cells.
© 2007 Elsevier Inc. All rights reserved.Keywords: Cochlea; Hair cell; Supporting cell; Progenitor cell; Organ culture; Notch signal; γ-Secretase inhibitor; TACE inhibitorIntroduction
Approximately 10% of the world's population suffers from
hearing loss. Cochlear hair cell damage is one of the most
important causes of sensorineural hearing loss; currently, there
are no available therapeutics for its treatment because mamma-
lian cochlear hair cells as against avian hair cells can never
regenerate spontaneously (Ryals and Rubel, 1988; Corwin and
Cotanche, 1988). It is very important to elucidate the molecular
mechanisms underlying hair cell development for application in
regenerative medicine.
Cochlear hair cells are sensory epithelial cells that transduce
mechanical sound signals into electrical signals recognized by
auditory neurons by using mechanoelectrical transduction⁎ Corresponding author. Fax: +81 75 753 9485.
E-mail address: honjo@mfour.med.kyoto-u.ac.jp (T. Honjo).
0012-1606/$ - see front matter © 2007 Elsevier Inc. All rights reserved.
doi:10.1016/j.ydbio.2007.04.035channels. Hair cells are precisely arranged to form one row of
inner and three rows of outer cells. These hair cells are sur-
rounded by several types of supporting cells.
During inner ear development, Notch signaling has been
implicated in the induction of supporting cell fate rather than
hair cell fate in the cochleae, based on studies on mice deficient
in Notch signaling-related genes (Lanford et al., 1999; Brooker
et al., 2006; Kiernan et al., 2001, 2005, 2006) and its
downstream genes (Zheng et al., 2000; Zhang et al., 2000;
Zine et al., 2001). By analyzing conditional knockout mice
having different Notch ligand genes, recent studies have
suggested that Notch signaling might also control the
proliferation of the supporting cell population (Kiernan et al.,
2005) and play several roles in the different developmental
stages of the cochlear sensory epithelium (Brooker et al., 2006;
Kiernan et al., 2006). However, the precise mechanisms by
which Notch signaling controls such cell differentiation pro-
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difficult to elucidate the roles of Notch signaling at different
developmental stages by the irreversible inactivation of Notch
signaling using gene-targeting technology.
Notch signaling is activated through the binding of ligands,
such as Jagged and Delta, to Notch receptors 1–4 (Tax et al.,
1994; Fleming, 1998). This binding initiates the proteolytic
cleavage of Notch receptors at their extracellular region by TNF-
alpha-converting enzyme (TACE) (Brou et al., 2000) and at
intramembranous regions by γ-secretase activity (De Strooper et
al., 1999; Mizutani et al., 2001). This cleavage releases the
intracellular domain of the Notch receptors (NICD) from the
membrane (Schroeter et al., 1998). NICD enters the nucleus,
forms a complex with the DNA-binding protein RBP-J, and
activates its target genes, thereby controlling cell differentiation
(Jarriault et al., 1995; Tamura et al., 1995; Honjo, 1996).
Yamamoto et al. showed that the γ-secretase inhibitor could
efficiently block Notch signaling in neonate mouse cochleae and
induced hair cells in cochlear explant cultures. Here, we
developed a novel in vitro culture and analysis method for
mouse fetal cochleae and addressed the regulation of inner ear
development by using Notch signaling inhibitors of TACE and
γ-secretase, both of which are independently required for Notch
activation (Fortini, 2002). One of the main advantages of using
these types of small molecule inhibitors is that the inactivation of
target signaling by these inhibitors is reversible unlike
irreversible inactivation by gene targeting; further, this culture
method is suitable for analyzing the multiple roles of Notch
signaling systems.
Taking advantage of these features, we showed that the
increase in hair cell number by the inhibition of Notch signaling
was due to hair cell differentiation from progenitor cells at the
expense of supporting cells. Prox1-positive immature support-
ing cells can differentiate into hair cells when Notch signaling is
inhibited. Moreover, we clearly showed that Notch signaling
played a role in arresting the cell cycles of cochlear epithelial




Time-pregnant ICR mice were purchased from Japan SLC, Inc. (Hama-
matsu, Japan). All experiments were performed in accordance with the
guidelines of the animal research committee, Graduate School of Medicine,
Kyoto University.
Explant culture of cochleae
Inner ears were dissected from the heads of embryonic day (E) 12.5, 13.5,
14.5, or 17.5 embryos by using forceps under a LEICAMZ7.5 stereomicroscope
(Leica Microsystems,Wetzlar, Germany). The cochlear epitheliumwas removed
mechanically from the cochlear bone in PBS and cut at the hook region. Spiral
ganglion neuron cells remained attached to the cochlear epithelium although
most mesenchymal cells were removed. The entire cochlear epithelium with
attached spiral ganglion neurons was placed in a 30-μl drop of type I rat collagen
at a final concentration of 2.5 mg/ml (Sigma-Aldrich, St. Louis, MO, USA) in
10 mM HEPES buffer (Invitrogen, Carlsbad, CA, USA), 1 mM HCl, 1× MEM
(Invitrogen), and 0.5% NaHCO3 (Invitrogen). After waiting for the drop to gelfor 30 min at 37 °C at 5% CO2, we added 200 μl of DMEM supplemented with
6 mg/ml glucose (Wako, Osaka, Japan) and 0.6 mg/ml penicillin G (Nacalai
Tesque, Kyoto, Japan). The culture was incubated at 37 °C in a humidified 5%
CO2 atmosphere. The culture medium was replaced every day. N-[N-(3,5-
Difluorophenacetyl-L-alanyl)]-S-phenylglycine t-butyl ester (DAPT; EMD
Biosciences, San Diego, CA, USA) was used as a γ-secretase inhibitor and
N-(R)-[2-(hydroxyaminocarbonyl)methyl]-4-methylpentanoyl-L-naphthylala-
nyl-L-alanine-2-aminoethyl amide (TAPI-1; EMD Biosciences) or N-(R)-[2-
(hydroxyaminocarbonyl)methyl]-4-methylpentanoyl-L-t-butyl-alanyl-L-alanine-
2-aminoethyl amide (TAPI-2; EMD Biosciences) was used as a TACE inhibitor
to inhibit Notch signaling. In a (+)-5-bromo-2′-deoxyuridine (BrdU, Sigma-
Aldrich) experiment, the culture medium was supplemented with BrdU at a final
concentration of 3 μg/ml. DAPT, TAPI-1, or BrdU was dissolved in DMSO
(Sigma-Aldrich); the final DMSO concentration in the culture medium was less
than 0.1%. The control samples were supplemented with the same concentration
of DMSO as the drug-treated samples.
Immunohistochemistry
Cultured cochleae surrounded with collagen were fixed at 4 °C for 30 min in
4% paraformaldehyde (Nacalai Tesque) after washing with PBS. For whole
mount immunohistochemistry, whole cochleae were permeabilized with 0.2%
Triton X in PBS for 1 h, blocked with 1.5% goat serum for 1 h, and then
immunostained with primary and secondary antibodies. For whole mount
immunohistochemistry performed using anti-BrdU antibodies, antigen retrieval
was accomplished by incubation in 2 M HCl for 30 min at 37 °C before
blocking. The immunostained sensory cochlear epithelium was removed from
the whole cochleae under a LEICA MZ FLII fluorescence stereomicroscope
(Leica Microsystems), placed in the aqueous mounting medium Permafluor
(Beckman Coulter, Fullerton, CA, USA) on a slide glass, and covered with a
coverglass. For frozen sections, the fixed cochleae were immersed in 30%
sucrose at 4 °C overnight after fixation and then the surrounding collagen was
removed. The whole cochleae were placed in OCT compound (International
Medical Equipment, San Marcos, CA, USA) such that the basal turn of the
cochleae were arranged in the same direction under a LEICA MZ7.5
stereomicroscope and preserved at −80 °C. Frozen sections were cut at
10 μm, mounted on slide glasses, and immunostained. Antigen retrieval was
performed by incubation in 10 mM sodium citrate buffer (pH 6.0) with 0.5%
Tween 20 for 20 min at 95 °C. For immunohistochemistry performed using
biotinylated secondary antibodies, the sections were incubated for 30 min in
absolute methanol containing 1% H2O2 to inhibit endogenous peroxidase
activity. The sections were permeabilized, blocked, and immunostained as in the
case of whole mount immunostaining. An avidin-biotinylated enzyme complex
(ABC) kit (Vector Laboratories, Burlingame, CA, USA) and a diaminobenzidine
(DAB) substrate kit (Vector Laboratories) were used for DAB staining
performed using the ABC method. Nuclei were counterstained with hematox-
ylin or TOTO3 (1:10000; Invitrogen). The VECTASHIELD mounting medium
(Vector Laboratories) was used as a mounting medium for fluorescence sections.
The following are the primary antibodies used in the indicated dilutions for the
sections: anti-myosin VI rabbit antibodies (1:800, provided by Dr. Tama
Hasson; UCSD, CA, USA), anti-myosin VIIa rabbit antibodies (1:600, provided
by Dr. Tama Hasson), anti-Prox1 rabbit antibodies (1:100; AngioBio, Del Mar,
CA, USA), anti-p27 rabbit antibodies (1:100; Lab Vision, Fremont, CA, USA),
anti-S100A1 rabbit antibodies (1:100; Lab Vision), anti-BrdU mouse antibodies
(1:50; BD Biosciences, San Jose, CA, USA), and anti-NICD rabbit antibodies
(1:80; Cell Signaling Technology, Danvers, MA, USA). The following
secondary antibodies were used: Alexa Fluor 488 goat anti-rabbit IgG antibodies
(1:400; Invitrogen), Alexa Fluor 594 goat anti-mouse IgG antibodies (1:250;
Invitrogen), Alexa Fluor 594 goat anti-rabbit IgG antibodies (1:250; Invitrogen),
Alexa Fluor 633 phalloidin (1:1000; Invitrogen), and biotinylated goat anti-
rabbit IgG (H+L) antibodies (1:200; Vector Laboratories). The primary or
secondary antibodies for whole mount immunohistochemistry were used at half
the dilution that was used for the frozen sections. The samples for immuno-
fluorescence were observed with a Leica TCS SP2 confocal microscope (Leica
Microsystems). The sections stained by the ABC method were mounted in
xylene and observed under a Leica DM5000B microscope (Leica Micro-
systems). The images were imported into Paintshop (Jasc Software, Inc., Eden
Prairie, MN, USA), and saved as Tiff files.
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The whole images were captured with LEICA MZ7.5 stereomicroscope or
Axiovert 200 inverted microscope (Carlzeiss, Göttingen, Germany). The
cochlear duct length or the sensory epithelium length was calculated with
Image J (Rasband, W.S., National Institutes of Health, USA, http://www.rsb.
info.nih.gov/ij/, 1997–2006). The average length was calculated.
FM 1–43 uptake experiment
E14.5 cochleae were cultured for 6 days in the absence or presence of
5 μM DAPT for the first 2 days and then for the following 4 days in a normal
medium (DMEM supplemented with glucose and penicillin) in collagen gel.
After the 6-day culture, they were incubated in a culture medium containing
5 μM FM® 1–43FX – a fixable analog of the FM® 1–43 membrane stain
(Invitrogen) for 1 min and then fixed immediately using 4% paraformaldehyde.
The cochlear epithelium was removed and placed on a slide glass as soon as
possible. Green fluorescence was captured with a Leica TCS SP2 confocal
microscope.
Hair cell and supporting cell count
Samples for whole mount immunohistochemistry were prepared as follows.
The cultured cochlear epithelium was placed on a slide glass after whole mount
simultaneous immunohistochemistry for myosin VIIa and phalloidin and
observed using confocal microscopy. We defined myosin VIIa-positive cells
with stereocilia-like actin filaments on the apical surface as hair cells. The
number of hair cells was counted through at least more than 400 μm from the
middle to the basal turn of the cochlea; the end point of counting was at a
distance of approximately 100 μm from the hook region. The number of hair
cells per 100 μm of the length of the cochlea was calculated and the average
number of hair cells in each sample was calculated.
The samples for immunohistochemistry on frozen sections were prepared as
follows. Vertical sections of the cochlear duct were obtained. Sections that
included the basal turn of the cochlea were selected for analysis. Serial frozen
sections were immunostained with anti-myosin VI or anti-Prox1 antibodies. We
defined cells positive for myosin VI and for Prox1 in the nucleus as hair and
supporting cells, respectively. The number of hair cells or supporting cells was
counted, and the average numbers of these cells were calculated. In order to
determine the total number of hair cells and supporting cells, adjacent serial
sections were selected and the total number of hair and supporting cells were
summed up and then averaged.
Quantitative RT–PCR
Total RNA was prepared from E14.5 cochleae cultured for 2 days in the
absence or presence of DAPT. cDNAwas synthesized from DNase I-treated total
RNA that was extracted from 10 cultured cochleae, as previously reported
(Yamamoto et al., 2006). Quantitative RT–PCR was performed for cyclophilin,
Hes1, Hes5, Atoh1, or Arbp with previously reported primers (Yamamoto et al.,
2006). Arbp was used as an internal control. The expression level of each
mRNAwas normalized by that of Arbp mRNA and then the relative expression
level of each mRNAwith or without DAPT treatment was calculated against the
expression level of the mRNA without DAPT treatment. The experiment was
performed three times, and the average of the results was presented.
BrdU index experiment
E14.5 cochleae were cultured for 2 days in the absence or presence of
5 μM DAPT. A concentration of 3 μg/ml BrdU was added as a supplement
only for the last 24 h. Vertical sections that included the basal turn of the
cochlea were selected for analysis. Frozen sections of the cultured cochleae
were treated with citrate buffer and immunostained with BrdU and counter-
stained using TOTO3. Images of the samples were captured using a confocal
microscope. The BrdU index was calculated by dividing the number of BrdU-
positive cells in the cochlear basal turn in one slice by the total number of
cochlear epithelial cells that were determined by counting the number ofTOTO3-positive cells in the cochlear basal turn in one slice. The average of the
BrdU indexes was presented.
Statistical analysis
Statistical significance was calculated by Student's t-test. Error bars show
the mean±standard error of the mean (SEM).Results
Establishment of fetal cochlear explant culture
Fetal organ culture of the inner ears of mice has been
reported since the 1970s (Van de Water et al., 1973). However,
despite its usefulness, only a few studies have thus far used
mouse fetal cochlear explant culture (Kelley et al., 1993;
Montcouquiol and Kelley, 2003; Miura et al., 2004; Woods et
al., 2004). We thought that the difficulties encountered in the
dissection of fetal cochleae, particularly when removing the
roofs of cochleae, and in the analysis of samples prevented
many investigators from using this technique. To overcome
these difficulties, we used collagen gel as a surrounding
support tissue in the preparation of the explant culture.
Collagen gel is often used to examine chicken ear develop-
ment (Ladher et al., 2000). If cochleae are placed with at-
tached spiral neurons in the gel and cultured in DMEM
supplemented with glucose, the cochlear duct can elongate
(Supplementary Fig. 1). The increase rate of the cochlear duct
length was 72.2±9.6% in the in vitro 8-day culture from
E12.5, 61.9±4.1% in the 6-day culture from E14.5, or 21.5±
3.0% in the 3-day culture from E17.5, respectively (Supple-
mentary Fig. 1F). This result of the in vitro culture from E14.5
or E17.5 was similar to the in vivo development (Mckenzie et
al., 2004) though that from E12.5 was insufficient compared
to the in vivo development.
To analyze in detail the images of all the samples, whole
mount immunohistochemistry was first performed without
removing the collagen gel (Figs. 1A–C); the sensory
epithelium was then detached from the gel and roofs of
the cochleae under a fluorescence stereomicroscope, and the
preservation of the structure of the epithelium was ex-
amined. Next, by placing the detached sensory epithelium
flat on a slide glass, detailed pictures were obtained by
confocal microscopy.
For frozen sections, before soaking the samples in OCT
compound, collagen gel was gently removed, and the cochleae
were arranged in the OCT compound in the same direction so
that cochlear orientation could be easily identified.
Our system offers certain advantages over the previously
reported explant culture systems. First, since this is a 3D
culture, the environment was more similar to in vivo
conditions as compared with that in previously reported
systems. Second, we do not need to be concerned about the
effects of unknown supplements because unlike systems that
use Matrigel® or fetal calf serum whose compositions cannot
be precisely determined, we only use high glucose and
collagen concentrations.
Fig. 1. Hair cell increase by Notch signaling inhibitors. (A–J) E14.5 cochleae were cultured for 2 days in the absence (A, E, I) or presence (B, F–H, J) of 5 μMDAPT
(B, F, J), 50 μM TAPI-1 (G), or 50 μM TAPI-2 (H) and for the following 4 days in normal culture medium, or for 6 days in the presence of 5 μM DAPT (C). Whole
mount immunohistochemistry for myosin VIIa (A–C, red, E–H, green) and phalloidin (E–H, red) and the FM 1–43 uptake experiment (I, J) were performed. Myosin
VIIa-positive area was wider with DAPT treatment (B, C) than without DAPT treatment (A) though that length from the basal turn to the apical turn was no statistical
difference (n=17, D). Two-day treatment of E14.5 cochleae with DAPT (F, J), TAPI-1 (G), or TAPI-2 (H) increased hair cell number in cochleae compared to the
control culture (E, I). (K) Hair cell number was counted after DAPT treatment. E12.5 (n=10), E14.5 (n=12), or E17.5 (n=5) cochleae were cultured in the absence or
presence of DAPT (1 or 5 μM) for 2 days and for the following 5, 4, and 3 days, respectively, in a normal culture medium. Error bars indicate SEM of data. Asterisks:
pb0.001 between control and DAPT-treated cochleae. Brackets show hair cell areas. Lower left boxes show culture patterns. The width of the boxes indicates the
culture period. White boxes show the duration of culture in a normal medium, and red boxes show the duration of drug treatment. Scale bars indicate 100 μm (A–C) or
20 μm (E–J). The upper, lower, right, and left sides of the images indicate the apical, basal, medial, and lateral sides of the samples, respectively. GER: greater
epithelial ridge.
168 S. Takebayashi et al. / Developmental Biology 307 (2007) 165–178Notch signaling inhibitors increased hair cell numbers in
E14.5 cochleae
Since disruption of the genes in the Notch signaling pathway
causes an increase in the number of hair cells in developmental
cochleae (Lanford et al., 1999; Zheng et al., 2000; Zhang et al.,
2000; Zine et al., 2001; Brooker et al., 2006; Kiernan et al.,
2001, 2005, 2006), it is expected that the treatment of fetal
cochleae with Notch signaling inhibitors will increase the
number of hair cells. We used inhibitors of γ-secretase or TACE
that are required for Notch receptor cleavage. This time, we
used DAPT as a γ-secretase inhibitor; this molecule can inhibit
Notch signaling in a more specific manner than MDL280170 –
another type of γ-secretase inhibitor that is used in neonatal
cochlear explant culture (Yamamoto et al., 2006).
We first treated the E14.5 cochlear explant culture with
DAPT because Hes1 and Hes5 – the direct downstream mole-
cules of Notch signaling in the cochlear sensory epithelium –are expressed in cochleae from E14 (Zine et al., 2001). The
E14.5 cochleae were cultured for 2 days in the absence or
presence of 5 μM DAPT and for the following 4 days in a
normal culture medium, or in the presence of 5 μM DAPT for
6 days. Whole mount immunohistochemistry for anti-myosin
VIIa antibodies was performed. Myosin VIIa is a hair cell
marker. In the presence of DAPT, the sensory epithelium area
(myosin VIIa-positive area) was wider than in the absence of
DAPT (Figs. 1A–C). There was no marked statistical difference
in the length of the sensory epithelium from the basal turn to the
apical turn of the cochleae that were cultured with or without
DAPT (Fig. 1D). We counted the number of myosin VIIa-
positive cells as hair cells in the mid-basal turn through more
than 400 μm of cochlear length and determined the number of
hair cells per 100 μm. In the 6-day DAPT treatment, we could
not determine the number of hair cells since many dense hair
cells were observed. The 2-day DAPT treatment increased the
number of hair cells in a dose-dependent manner (Figs. 1E, F,
Fig. 2. DAPT treatment inhibits Notch signaling. (A–D) Serial frozen sections
of cochleae cultured from E17.5 embryos for 2 days in the absence (A, C) or
presence (B, D) of 5 μM DAPT. (A, B) NICD (brown) counterstained with
hematoxylin (blue). (C, D) Prox1 (green) counterstained with TOTO3 (blue).
NICD staining in the nuclei (arrows in A) of supporting cells, including Prox1-
positive cells (arrows in C) was negative (B), and Prox1-positive cell numbers
decreased (D) with DAPT treatment. Dotted lines show hair cell areas. Black
arrows indicate the NICD-positive supporting cells (A), and white arrows
indicate the Prox1-positive supporting cells. Red and white boxes in the lower
left corner of each image show that the culture was treated with and without
DAPT, respectively. Single asterisks indicate the cochlear duct. Scale bars
indicate 20 μm. The upper, lower, right, and left sides of the images indicate the
apical, basal, medial, and lateral sides of the samples, respectively. (E) The
relative amount of mRNA expression of cyclophilin, Hes1, Hes5, or Atoh1 was
evaluated by quantitative RT–PCR in the cochleae cultured from E14.5 embryos
for 2 days in the absence or presence of DAPT (1 or 5 μM). DAPT treatment
decreased the Hes1 or Hes5 mRNA expression level but increased the Atoh1
mRNA expression level.
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even when cochleae were immunostained with antibodies
against other hair cell markers such as myosin VI, calmodulin,
or parvalbumin (data not shown).
Moreover, FM 1–43 that enters functional hair cells spe-
cifically through the mechanoelectrical transduction channel
(Gale et al., 2001) was observed in hair cells induced by DAPT
treatment as well as in those of control samples (Figs. 1I and J).
These results clearly show that the treatment of E14.5 cochleae
with DAPT increased the number of functional hair cells.
Next, we treated the E14.5 cochlear explant culture with a
TACE inhibitor, i.e., either TAPI-1 or TAPI-2, that blocks
Notch receptor cleavage by a mechanism different from that
used by the γ-secretase inhibitor. Treatment with either TAPI-
1 or TAPI-2 increased the hair cell number in E14.5 cochleae
in a dose-dependent manner as in the case of DAPT treatment
(Figs. 1E–H).
Both types of Notch signaling inhibitors, i.e., the γ-secretase
inhibitor and TACE inhibitor, inhibit Notch receptor cleavage
by different mechanisms; however, they can both still increase
the number of hair cells in the same manner. These results
suggest that the treatment of E14.5 cochleae with Notch
signaling inhibitors can increase the hair cell number.
Notch signaling inhibitors increased hair cell number only
after E14.5
To check when Notch signaling inhibitors begin to increase
hair cell number, the E12.5 and E17.5 cochlear explant cul-
tures were treated with DAPT for 2 days; after a 2-day DAPT
treatment, these explants were cultured for 5 and 3 days to wait
for hair cell maturation, respectively, in normal media. Hair
cell number was determined as described in the E14.5 culture
experiment.
In the E12.5 cochlear culture, there was no statistical dif-
ference between hair cell number in the DAPT-treated samples
and control samples (Fig. 1K). In the E17.5 cochlear culture,
hair cell number increased in the DAPT-treated samples
compared to the control samples (Fig. 1K). These results
show that treatment with Notch signaling inhibitors has the
potential to increase hair cell number only after E14.5.
Notch signaling inhibitor treatment inhibited Notch signaling
in fetal cochleae
To confirm that Notch signaling inhibitors can inhibit Notch
signaling in cochleae, we adopted two different strategies. First,
immunohistochemistry for NICD was performed. E17.5
cochleae were cultured for 2 days in the absence or presence
of 5 μM DAPT, and then serial frozen sections of cochleae
were prepared and immunostained with anti-NICD or anti-
Prox1 antibodies. Prox1 was reported as a good immature
supporting cell marker in cochleae (Bermingham-McDonogh
et al., 2006).
In the absence of DAPT, NICD was detected in the nucleus
of supporting cells, including Prox1-positive supporting cells
(arrows in Figs. 2A and C). On the other hand, in the presence ofDAPT, NICD was absent in the nuclei of supporting cells (Figs.
2B, D). This result suggests that DAPT treatment inhibited the
translocation of NICD to the nucleus and, in turn, inhibited
Notch signaling.
Second, we examined how DAPT treatment affected the
transcription of Notch downstream genes by quantitative
RT–PCR. Total RNA was prepared from E14.5 cochleae
cultured for 2 days in the absence or presence of DAPT.
Quantitative RT–PCR was performed for Hes1, Hes5, Atoh1,
cyclophilin, or Arbp. Hes1 and Hes5 were reported as direct
targets of Notch signaling (Ohtsuka et al., 1999), and both have
roles in regulating hair cell number (Zine et al., 2001). Atoh1 is
indispensable for hair cell differentiation (Bermingham et al.,
1999), and its expression is inhibited by Notch signaling through
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Yamamoto et al., 2006). The expression level of each mRNA
was normalized by that of Arbp, and then the relative expression
level of each mRNA with or without DAPT treatment was
calculated against the mRNA expression level in the cochleae
cultured without DAPT (Fig. 2E).
DAPT treatment decreased Hes1 and Hes5 mRNA
expression levels and increased Atoh1 expression level in a
dose-dependent manner. These results, when combined with
the results of NICD immunohistochemistry, suggest that
DAPT treatment inhibited Notch receptor cleavage. This
resulted in a decrease in the transcription of Notch down-
stream targets, for example, Hes1 or Hes5, and thereby
increased Atoh1 mRNA expression level to induce hair cell
differentiation.
Increase in hair cell number by Notch signaling inhibitor
treatment was not due to hair cell proliferation
Next, we checked the mechanisms of hair cell increase by
Notch signaling inhibitors. E14.5 cochleae were cultured in the
absence or presence of 5 μM DAPT with continuous supple-
mentation with 3 μg/ml BrdU. Serial frozen sections were
prepared from cochlear explant cultures and immunostained
with anti-myosin VI, anti-Prox1, or anti-BrdU antibodies.
Myosin VI is a hair cell marker occurring at an earlier stage in
development than myosin VIIa (Montcouquiol and Kelley,
2003). We defined myosin VI-positive cells as hair cells and
Prox1-positive cells in the nucleus as supporting cells, and
Nuclei were counterstained with TOTO3. Hair cells or
supporting cells were not observed in the E14.5 cochleae before
culture (Figs. 3A and D).
First, to check whether hair cells proliferate, we examined
whether BrdU-positive hair cells appeared. Hair cells were
negative for BrdU in the short-time culture although hair cells
increased with DAPT treatment (Figs. 3B, C). This was also
observed in E17.5 cochlear explant cultures (data not shown)
and in an explant culture treated with TACE inhibitors
(Supplementary Fig. 2). These results suggest that the increase
in hair cell number by Notch signaling inhibitor treatment is not
due to hair cell proliferation.Fig. 3. Hair cell increase by Notch inhibition and supporting cell induction by the rea
with anti-myosin VI (A–C, G–I; green), anti-Prox1 (D–F, J–L; green), or anti-Br
medium. DAPT concentration was 5 μM. Nuclei were counterstained with TOTO3
intraperitoneally injected 30 min before sacrifice. Myosin VI or Prox1 was negative i
with 5 μMDAPT treatment (C, F) or without DAPT treatment (B, E). With DAPT tre
compared to the control culture (B, E). Increased hair cells with DAPT treatment were
treatment. (H and K) Two-day 5 μM DAPT treatment and 4-day culture in normal m
experiment (K), BrdU-negative and Prox1-positive supporting cells (SCs) were ob
(n=10) and for 6 days in three manners (n=10) described above.We defined myosin V
cells and counted the numbers of each type of cells. The total number of hair cells and
Notch signaling role. Notch signaling inhibits hair cell (HC) differentiation from non
differentiation from PCs. (O) E17.5 cochleae were cultured for 2 days in two manners
cell type of cells, as was done for the E14.5 cochleae described above. (P) A mode
Prox1-positive supporting cells (SCs) to hair cells (HCs). The brackets in the imag
indicate no supplementation with DAPT, DAPT supplementation, and BrdU supplem
right, and left sides of the images indicate the apical, basal, medial, and lateral sides
circles: Control samples cultured for 2 or 6 days without DAPT treatment. Green t
following 4 days in normal medium. Red boxes: Samples treated with DAPT continNotch signaling inhibition decreased supporting cell numbers
Since common progenitor cells of hair and supporting cells
give rise to both types of cells (Fekete et al., 1998) with cell fate
specification probably determined by using Notch signaling, we
checked the number of supporting cells. In the DAPT-treated
samples, Prox1-positive supporting cell numbers decreased
compared with those in the control samples, although DAPT
treatment increased hair cell number (Figs. 3A–F and M). The
total number of hair cells and supporting cells was similar in
DAPT-treated samples and control samples (Fig. 3M).
We also used S100A1 as another supporting cell marker
although inner hair cells as well as supporting cells test positive
for S100A1 (Coppens et al., 2001). The number of S100A1-
positive supporting cells also decreased in the presence of
DAPT; this is similar to the decrease in the number of Prox1-
positive supporting cells (data not shown). In addition, TACE
inhibitors increased hair cell and decreased supporting cell
numbers (data not shown). Moreover, we could not detect the
apoptosis in the sensory epithelium irrespective of DAPT
treatment though it was observed in mesenchymal cells (data
not shown). These results suggest that Notch signaling
inhibition induces hair cells at the expense of supporting
cells, and as a result, hair cell numbers increase.
Notch signaling is required for the induction of Prox1-positive
supporting cells
Notch signaling inhibitor treatment at the E14.5 develop-
mental stages of cochleae for only 2 days caused the loss of
Prox1-positive supporting cells (Figs. 3E, F, and M), suggesting
that Notch signaling is required for the induction of these cells.
To clarify this role of Notch signaling, we analyzed the recovery
of Prox1-positive supporting cells by washing out the Notch
signaling inhibitor after treatment (Figs. 3G–M).
After a 2-day culture in the presence of 5 μM DAPT, the
inhibitor was washed out, and cochlear explants were
continuously cultured for 4 more days in a normal medium.
As positive and negative controls, cochlear explants were
cultured for 6 days in the presence and absence of 5 μM DAPT,
respectively.ctivation of Notch signaling. (A–L) Serial frozen sections were immunostained
dU (A–L, red) antibodies. BrdU was continuously supplemented into culture
(A–F, blue). (A and D) Normal E14.5 cochleae into whose mother BrdU was
n the sensory epithelium. (B, C, E, and F) Two-day culture cochleae from E14.5
atment, hair cells increased (C) and Prox1-positive supporting cells decreased (F)
negative for BrdU (C). (G–L) Six-day culture cochleae from E14.5. (G and J) No
edium after washout. I and L: Six-day 5 μM DAPT treatment. In the washout
served (arrows). (M) E14.5 cochleae were cultured for 2 days in two manners
I-positive cells as hair cells and Prox1-positive cells in the nucleus as supporting
Prox1-positive supporting cells of serial sections was calculated. (N) A model of
-dividing progenitor cells (PCs) and induces Prox1-positive supporting cell (SC)
(n=14) and for 6 days in three manners (n=9). We counted the numbers of each
l of Notch signaling role. Notch signaling inhibits the transdifferentiation from
es indicate hair cell areas. Arrows indicate SCs. White, red, and yellow boxes
entation, respectively. Scale bars in the images indicate 20 μm. The upper, lower,
of the samples, respectively. Error bars in M and O indicate SEM of data. Open
riangles: Washout samples cultured for the first 2 days with DAPT and for the
uously for 2 or 6 days. Double asterisks: pb0.001.
171S. Takebayashi et al. / Developmental Biology 307 (2007) 165–178As expected, with the 6-day DAPT treatment, hair cell
number increased (Fig. 3I and red box in Fig. 3M), and Prox1-
positive supporting cells disappeared (Fig. 3L and red box inFig. 3M); this was similar to the result observed in the E14.5
samples subjected to the 2-day DAPT treatment (Figs. 3B, C, E,
F, and M). However, Prox1-positive supporting cells
172 S. Takebayashi et al. / Developmental Biology 307 (2007) 165–178reappeared in the washout experiments (arrows in Fig. 3K), and
their number increased (green triangle in Fig. 3M). NICD
expression in the nucleus was also observed in the supporting
cells of the cochleae in the washout experiment (data not
shown). When BrdU was supplemented for 6 days in the
culture medium for E14.5 cochleae, the reappeared Prox1-
positive cells were negative for BrdU (arrows in Fig. 3K).
These results suggest the reactivation of Notch signaling
induces Prox1-positive supporting cells from non-dividing
progenitor cells.
Moreover, E12.5 or E13.5 cochleae were cultured for
6 days, as was done for E14.5 cochleae: no treatment, 2-day
DAPT treatment and 4-day culture in the normal medium after
washout, and 6-day DAPT treatment. As observed in E14.5
cochleae, Prox1-positive supporting cells were not observed
with the 6-day DAPT treatment (Supplementary Fig. 3F),
although they appeared in the control and washout experi-
ments (Supplementary Fig. 3D, E). When BrdU was sup-
plemented for 6 days in the culture medium for E12.5 or E13.5
cochleae, many BrdU-negative and Prox1-positive supporting
cells appeared (Supplementary Fig. 3D, E). These results
suggest that the reappearance of Prox1-positive supporting
cells in the washout experiments is not due to supporting cell
proliferation, but due to differentiation from non-dividing
progenitor cells that appear to exist in E14.5 or earlier
embryos. Notch signaling induces Prox1-positive supporting
cell fate in non-dividing common progenitors of hair cells and
supporting cells in addition to the inhibition of hair cell
differentiation (Fig. 4N).Fig. 4. Notch signaling inhibits cell proliferation of cochlear epithelial cells containin
2 days in the absence (A, C) or presence (B, C) of 5 μMDAPTwith 3 μg/ml BrdU sup
anti-myosin VI (A and B, green) and anti-BrdU (A and B, red) antibodies simultaneo
was calculated in the basal turn. BrdU index (%)=(BrdU-positive cells in the cochlea
and B))×100. The average BrdU index was calculated (C). The BrdU index was high
absence (B, C) of DAPT. Black double asterisks: pb0.001 between the control an
signaling inhibits progenitor cell (PC) proliferation (left). Notch inhibition with the
incorporate BrdU (pink circles). (E–G) E17.5 (n=4) cochleae were cultured for
supplementation with 3 μg/ml BrdU. Whole mount immunohistochemistry for myosin
hair cells (arrows in E, F). BrdU-positive hair cell numbers were counted through a le
BrdU-positive hair cell numbers per 100 μm were calculated (F). Black triple asteris
hair cells were observed in the middle turn than in the basal turn of the cochleae (G
cultured for 6 days in the absence (H, K) or presence (I, J, L) of 5 μMDAPT supplem
L). Frozen sections were prepared and immunostained with anti-myosin VI (H, I, K, L
were observed in the presence of DAPTwith the supplementation with BrdU only for
cells were not observed in the cochleae with the supplementation with BrdU only fo
cultured for 6 days in the absence or presence of 5 μMDAPTwith continuous supplem
turn was counted per section, and the average number of these cells was calculated. A
than in the absence of DAPT, and younger cochleae tended to have more BrdU-posi
asterisks: pb0.005, between control and DAPT-treated cochleae. (N) A model of the
can divide; PC2, progenitor cell after final cell division; HC, hair cell; SC, supportin
supplementation. Notch signaling arrests the cell cycle of PC1, and PC1 seldom inco
model of a short-time culture treated with a Notch inhibitor and BrdU supplement. P
signaling inhibitor and differentiates into PC2 containing BrdU. However, PC2 conta
A long-time culture model with a Notch inhibitor and with early temporary BrdU su
Some PC2 cells contain BrdU (pink circles) because these cells differentiate from PC
containing BrdU with Notch signaling inhibitor treatment differentiates into HCs. Lo
(arrows). On the other hand, SCs decrease in number with Notch inhibition (dotted
cochlear duct. Lower left boxes in the images show the culture supplement pattern. W
and BrdU supplement, respectively. Scale bars in images indicate 20 μm. The upper
lateral sides of the samples, respectively. Error bars in the graphs indicate SEM of dNotch signaling is required for the maintenance of E17.5
supporting cells
However, the 2-day DAPT treatment of E17.5 cochleae
increased the number of hair cells and decreased the number of
Prox1-positive supporting cells (Figs. 1K and2D) althoughhair and
supporting cell fates were already determined and Prox1-positive
supporting cells were observed in E17.5 cochleae (Supplementary
Fig. 4E). Notch signaling is probably required for the maintenance
of supporting cells in addition to their induction.
E17.5 cochleae were cultured in the absence or presence of
5 μM DAPT for 6 days. Hair cell number increased and Prox1-
positive supporting cells disappeared in the samples subjected
to the 6-day DAPT treatment compared to the non-treated
samples (red boxes in Fig. 3O and Supplementary Fig. 4D, H
vs. open circles in Fig. 3O and Supplementary Fig. 4B, F). The
number of S100A1-or p27-positive supporting cells similarly
decreased in the samples subjected to the DAPT treatment
(Supplementary Fig. 4L, P) compared to the non-treated
samples (Supplementary Fig. 4J, N). The same results were
obtained with the TACE inhibitor treatment (data not shown).
The disappearance of Prox1-, S100A1-, and p27-positive
supporting cells following the treatment of E17.5 cochleae
with the Notch signaling inhibitor suggests that Notch signaling
is also involved in the maintenance of these cell populations.
In contrast to E14.5 cochleae, Prox1-positive supporting
cells in E17.5 cochleae seldom reappear in the washout
experiment (green triangle in Fig. 3O and Supplementary Fig.
4G). In addition, S100A1- and p27-positive supporting cellsg hair cell progenitor cells. (A–C) E14.5 (n=6, A–C) cochleae were cultured for
plement for the last 24 h. Frozen sections were prepared and immunostained with
usly. Nuclei were counterstained with TOTO3 (A and B, blue). The BrdU index
r epithelium (B, arrows)/total number of cochlear epithelial cells (dotted line in A
er in E14.5 cochleae that were cultured in the presence (A, C) rather than in the
d DAPT-treated cochleae. (D) A model of the role of Notch signaling. Notch
Notch signaling inhibitor treatment activates the cell cycle of PCs, and these
6 days in the absence (D) or presence (E) of 5 μM DAPT with continuous
VIIa (red) and BrdU (green) shows that DAPT treatment induces BrdU-positive
ngth of 500 μm of the middle or basal turn (E, F) of the cochleae, and the average
ks: pb0.005 between control and DAPT-treated cochleae. More BrdU-positive
). n.d.: not detected. GER: greater epithelial ridge. (H–L) E17.5 cochleae were
ented with 3 μg/ml BrdU only for the first 24 h (H–J) or only for the last 24 h (K,
; green), BrdU (H–L, red), or Ki67 (J, green) antibodies. BrdU-positive hair cells
first 24 h (arrow in I) and were negative for Ki67 (arrow in J). BrdU-positive hair
r last 24 h (L). (M) E12.5 (n=5), E13.5 (n=7), or E14.5 (n=9) cochleae were
entation with 3 μg/ml BrdU. The number of BrdU-positive hair cells in the basal
greater number of BrdU-positive hair cells were observed in the presence rather
tive hair cells than older cochleae. Black double asterisks: pb0.001; black triple
prolonged culture experiments with a Notch inhibitor. PC1, progenitor cell that
g cell. (i) A model of normal culture without a Notch inhibitor and with a BrdU
rporates BrdU (pink circles). Therefore, PC2 cells seldom contain BrdU. (ii) A
C1 completes the cell cycle and incorporates BrdU (pink circles) with the Notch
ining BrdU does not yet differentiate into HCs or SCs in a short-time culture. (iii)
pplementation. Long treatment with the Notch inhibitor for all culture periods:
1 cells containing BrdU with early Notch signaling inhibitor treatment (ii). PC2
ng-time culture with the Notch signaling inhibitor results in BrdU-positive HCs
circle). Brackets in images show HC areas. White single asterisks indicate the
hite, red, and yellow boxes indicate no DAPT supplement, DAPT supplement,
, lower, right, and left sides of the images indicate the apical, basal, medial, and
ata.
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number of hair cells and supporting cells was similar in DAPT-
treated and control E17.5 cochleae (Fig. 3O), suggesting that
there are few non-dividing common progenitors of hair cells
and supporting cells in E17.5 cochleae. If this is the case, Prox1-
positive supporting cells may have the potential to differentiate
into hair cells, which are inhibited by Notch (Fig. 3P).
Inhibition of Notch signaling activates the cell cycle in a part
of E14.5 cochlear epithelium
It became evident that Notch signaling plays different roles
at different stages of development even within one tissue (Bray,2006). We checked whether Notch signaling inhibitor treatment
affected cell proliferation. E14.5 cochleae were cultured for
2 days in the absence or presence of DAPT (Figs. 4A–C). BrdU
was supplemented only during the last 24 h, and the BrdU index
was calculated by dividing the number of BrdU-positive cells in
the cochlear epithelium (arrows in Fig. 4B) by the total number
of cochlear epithelial cells (dotted line in Figs. 4A and B).
The BrdU index in E14.5 cochleae was higher in DAPT-
treated samples than in control ones (Figs. 4A–C). The results
suggest that Notch signaling inhibits the proliferation of
cochlear epithelial cells.
TACE inhibitor treatment also increased the number of
BrdU-positive cells around hair cells, although the effect of
174 S. Takebayashi et al. / Developmental Biology 307 (2007) 165–178TACE inhibitors was not as pronounced as that of DAPT
(arrows in Supplementary Fig. 2B, D). Notch signaling is
necessary to prevent some cochlear epithelial cell prolifera-
tion around hair cells at a specific time during development
(Fig. 4D).
Prolonged Notch inhibition leads to BrdU-positive hair cell
induction
We attempted a longer culture period along with supple-
mentation with BrdU to examine whether these BrdU-positive
cells were progenitors of hair cells because the BrdU-positive
cells may require more days to differentiate into hair cells.
First, whole mount immunohistochemistry for BrdU and
myosin VIIa was performed on E17.5 cochlear explants
cultured for 6 days in the absence or presence of 5 μM DAPT
with the 6-day supplementation with BrdU (Figs. 4E–G). BrdU-
positive hair cells were distinctly observed after the 6-day
culture with DAPT, although their numbers were very small
compared to the BrdU-negative hair cells (arrows in Figs. 4F
and G). BrdU-positive hair cells were mostly observed in the
region between the normal inner and outer hair cells (pillar cell
region) (arrows in Fig. 4F).
Moreover, frozen sections of E17.5 cochleae cultured with
DAPT for 6 days were immunostained with anti-myosin VI,
which served as another hair cell marker, and anti-BrdU
antibodies. When BrdU was supplemented only for the first
24 h, BrdU-positive hair cells were still observed and were
negative for the proliferating cell marker Ki67 in DAPT-treated
samples (arrows in Figs. 4I and J). On the other hand, when
BrdU was supplemented only for last 24 h, BrdU-positive hair
cells were not observed, although BrdU-positive cells were
observed around hair cells (Figs. 4K and L). In the 6-day culture
cochleae, the apoptosis was rarely detected in the sensory
epithelium (Supplementary Fig. 5). These results suggest that
DAPT treatment activates cochlear epithelial cell proliferation,
containing hair cell progenitors.
When we initiated treatment on E14.5, only DAPT-treated
samples contained BrdU-positive hair cells. However, when
treatment was initiated from E12.5 or E13.5, BrdU-positive
hair cells were observed even in the absence of DAPT (arrow
in Supplementary Fig. 3A). The number of BrdU-positive hair
cells was always found to be greater in DAPT-treated samples
than in control samples irrespective of the embryonic age of
the cochleae (Fig. 4M, and arrows in Supplementary Fig. 3A
and C). The number of BrdU-positive hair cells drastically
decreased after E12.5 as the number of hair cell progenitors
decreased.
Our results indicate that Notch signaling blocks the
proliferation of progenitor cells, which give rise to hair cells
(Fig. 4N).
Temporary DAPT treatment leads to BrdU-positive supporting
cell induction
If Notch signaling inhibits progenitor cell proliferation and
also regulates positively and negatively the generation of haircells and supporting cells, respectively, BrdU-positive support-
ing cells should appear by washing out DAPT after several days
of DAPT treatment with BrdU supplementation.
We cultured E14.5 cochlear explants in the presence of 5 μM
DAPT and BrdU for 4 days, washed out both DAPT and BrdU,
and continued culturing in a normal medium for the following
8 days (Fig. 5). As a control experiment, the same explants were
treated with DAPT for 12 days. Frozen sections of cochlear
explants were immunostained with anti-myosin VI (Figs. 5A–
C), anti-p27 (Figs. 5D–F), and anti-Prox1 (Figs. 5G–I) anti-
bodies. All these samples were simultaneously immunostained
with anti-BrdU antibodies (Figs. 5A–I). p27 was reported as
another supporting cell marker (Chen and Segil, 1999; Low-
enheim et al., 1999). BrdU and p27 double-positive supporting
cells (arrows in Fig. 5E) or BrdU and Prox1 double-positive
supporting cells (arrow in Fig. 5H) appeared only in washout
experiments. BrdU and p27 double-positive cells began to
appear 2 days after washout, and BrdU and Prox1 double-posi-
tive cells began to appear 7 days after washout (data not shown).
To determine whether the appearance of BrdU-positive
supporting cells was due to the proliferation of supporting cells
or differentiation from progenitor cells, the culture medium was
continuously supplemented with BrdU for the last 7 days (Figs.
5J, K). Most p27-positive supporting cells were negative for
BrdU (Fig. 5K), and all Prox1-positive cells were negative for
BrdU (data not shown). We therefore concluded that BrdU-
positive supporting cells were derived from progenitor cells,
which were induced with DAPT treatment and then differ-
entiated into supporting cells by the reactivation of Notch
signaling (Fig. 5L).
These results suggest that Notch signaling has multiple roles
in cochlear development: (1) the cell cycle arrest in some
cochlear epithelial cells, some of which may be common
progenitors of hair and supporting cells, (2) inhibition of hair
cell differentiation, (3) induction of Prox1-positive supporting
cell fate, (4) the maintenance of supporting cells to prevent the
transdifferentiation to hair cells (Fig. 6).
Discussion
We reported a novel in vitro 3D culture and analysis method
for mouse fetal cochleae and examined the roles of Notch
signaling by its reversible inhibition through the use of Notch
signaling inhibitors. In our culture system, cochlea elongation
was observed along with hair cell and supporting cell
differentiation. By using inhibitors of Notch signaling, the
number of hair cells increased only after E14.5 and involved the
downregulation of Notch targets, i.e., Hes1 and Hes5, and the
upregulation of Atoh1. These results were similar to those
already reported in in vivo experiments and show the validity of
our method. However, it will be necessary to improve the
method from the point of the insufficient cochlear duct
elongation in the in vitro culture from E12.5 compared to in
vivo development. Since our method uses only known factors, it
will be possible to examine the important factor for the cochlear
duct elongation from E12.5 by supplementing with known
factors one by one.
Fig. 5. Notch signaling is involved in progenitor cell proliferation of supporting cells.( A–K) E14.5 cochleae were cultured for 12 days (A–K). A, D, and G: No
treatment. B, E, H, J, and K: 4-day DAPT treatment and 8-day culture in normal medium after washout. C, F, and I: 12-day DAPT treatment. DAPTconcentration was
5 μM. A concentration of 3 μg/ml BrdU was supplemented only for the first 4 days from Day 0 to Day 4 (A–I) or only for the last 7 days from Day 5 to Day 12 (J, K).
Serial frozen sections were prepared and immunostained with anti-myosin VI (A–C, J, green), anti-p27 (D–F, K; green), anti-Prox1 (G–I, green), or anti-BrdU (A–K,
red) antibodies. Nuclei were counterstained with TOTO3 (A–K, blue). In the absence of DAPT, p27- (D) or Prox1- (G) positive supporting cells were observed, and
they were negative for BrdU (D, G). In the presence of DAPT, the number of p27- (F) or Prox1- (I) positive supporting cells decreased. In the washout experiment,
when BrdU was supplemented for the first 4 days (A–I), p27 and BrdU double-positive (arrows in E) or Prox1 and BrdU double-positive (arrow in H) supporting cells
were observed. On the other hand, when BrdU was supplemented for the last 7 days, p27 and BrdU double-positive supporting cells were seldom observed (K). (L) A
model of temporary Notch inhibition with the Notch signaling inhibitor and supplementation with BrdU only in early culture and recovery of Notch signaling in late
culture after washout of the Notch signaling inhibitor and BrdU. PC1, progenitor cell that can divide; PC2, progenitor cell after final cell division; HC, hair cell; SC,
supporting cell. (i) A model of normal culture without a Notch inhibitor. Since PC2 cells do not have BrdU (Fig. 5M(i)), BrdU-positive SCs are not observed. (ii) A
model of washout experiments (with short-time inhibitor treatment). PC2 cells containing BrdU (pink circle) appear due to differentiation from PC1 containing BrdU
with early Notch signaling inhibitor treatment (Fig. 5M(ii)). After the recovery of Notch signaling by inhibitor washout, BrdU-positive PC2 cells differentiate into SCs,
and BrdU-positive SCs begin to appear (arrows). HC number increases by early temporary Notch inhibition. Brackets show HC areas. White single asterisks indicate
the cochlear duct. Lower boxes show the culture supplement pattern. White, red, and yellow boxes indicate no supplementation with DAPT, DAPT supplementation,
and BrdU supplementation, respectively. Scale bars indicate 20 μm. The upper, lower, right, and left sides of the images indicate the apical, basal, medial, and lateral
sides of the samples, respectively.
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Fig. 6. (QAModel) of Notch signaling roles during hair cell and supporting cell
development in the cochlea. Model of the roles played by Notch signaling in
cochlear development. Notch signaling plays four roles in cochlear hair cell
(HC) and supporting cell (SC) development. (i) It arrests the cell cycle of HC
and SC progenitors. (ii) It inhibits HC differentiation. (iii) It induces SC
differentiation. (iv) It inhibits the transdifferentiation of SC. PC1, progenitor cell
that can divide; PC2, progenitor cell after final cell division; HC, hair cell; SC,
supporting cell. The gene names under the cell names in each circle are the gene
markers for each cell type.
176 S. Takebayashi et al. / Developmental Biology 307 (2007) 165–178Here, we propose a model of the roles played by Notch
signaling in cochlear development (Fig. 6). It is believed that
Notch signaling plays at least four roles in cochlear
development.
The first role of Notch signaling in cochlear development is
that it arrests the cell cycle in a part of the cochlear epithelium
that probably contains the progenitors of hair and supporting
cells (Fig. 6(i)).
In a Jagged2 and Dll1 mutant mouse, BrdU-positive hair
cells or BrdU-positive cells appeared around hair cells (Kiernan
et al., 2005). These results suggest that Notch signaling is
involved in cell proliferation. We obtained similar results from
our in vitro experiment (Fig. 4 and Supplementary Figs. 2 and
3). Notch signaling inhibitors induce cell proliferation,
particularly around pillar cell areas (Figs. 4F, I and Supple-
mentary Fig. 2B, D; arrows). Further, some BrdU-positive cells
could differentiate into hair cells (Figs. 4F, G, I, and M) with
prolonged DAPT treatment or supporting cells (Figs. 5E, H and
L) with temporary DAPT treatment. These results suggest that
these BrdU-positive cells induced by Notch inhibition are
progenitor cells of both hair and supporting cells and that Notch
signaling physiologically prevents the proliferation of progeni-
tor cells although we were not able to determine which Notch
downstream targets were involved.
Since p75-positive cells were observed around pillar cell
areas (Gestwa et al., 1999) and p75-positive cells can divide
and differentiate into hair cells at least in dissociation cell
cultures (White et al., 2006), it is possible that hair cell
progenitor cells, which can proliferate, exist around pillar cell
areas, and pillar cells themselves may be one of the candidates
of hair cell progenitors that can proliferate. Although we
attempted to examine p75 expression in BrdU-positive cells
around pillar cell areas, we could not clearly detect p75
expression by immunohistochemistry in cultures treated with
DAPT. More precise studies to determine where progenitorcells exist and what difference exist to choose the surrounding
cell fate between proliferation and differentiation will be
necessary.
The second role of Notch signaling is the inhibition of hair
cell differentiation (Fig. 6(ii)). By using the inhibitors of Notch
signaling, the number of hair cells increased, as was observed in
previous reports. In addition, we elucidate that supernumerary
hair cells originated not by the proliferation of hair cells
themselves but by differentiating from hair cell progenitors in
cochlear cultures treated with Notch inhibitors and BrdU
supplement.
The third role of Notch signaling is the induction of
supporting cell differentiation (Fig. 6(iii)). Notch inhibition
induces hair cell fate at the expense of supporting cell fate.
The results of our washout experiment suggest that Notch
signaling is physiologically required for supporting cell in-
duction from supposed progenitor cells (Figs. 3G–M and 5).
We suppose that ligands expressed on hair cells, for example
Jagged2 or Dll1, probably control supporting cell fate as
Woods reported that ectopic hair cells induced supporting cells
(Woods et al., 2004) although we were not able to determine
which ligands were involved. However, in the washout
experiment culture from E17.5, Prox1-positive supporting
cells seldom reappeared in spite of the generation of many hair
cells. On the other hand, BrdU and Prox1 double-positive
supporting cells appeared in the washout experiment culture
from E17.5 though the number was rare and the longer culture
time was required compared to E14.5 washout experiment
culture (data not shown). In the washout experiment culture
from E12.5, more BrdU and Prox1 double-positive supporting
cells were observed compared to that from E14.5 (Supple-
mentary Fig. 3). The induction of Prox1-positive supporting
cells by Notch signaling may be context-dependent and
required for another signals in addition to Notch signaling.
Future question remains which ligands or how level of Notch
signals are required for the supporting cell induction because
supporting cells are observed even in a Jagged2 and Dll1
mutant mice (Kiernan et al., 2005).
The fourth role of Notch signaling is the inhibition of
transdifferentiation from supporting cells to hair cells in
embryos (Fig. 6A(iv)) because Prox1-, S100A1-, or p27-
positive supporting cells disappear from DAPT-treated cochleae
at E17.5 when terminal mitosis has occurred (Ruben, 1967) and
cell fate should have already been determined (Fig. 3O and
Supplementary Fig. 4E–P). It is reported that p27-positive
supporting cells can differentiate into hair cells (White et al.,
2006). In addition, these results suggest that Prox1-positive
supporting cells have the potential to differentiate into hair cells
by Notch inhibition.
However, Prox1 expression in the supporting cells
gradually disappears as postnatal animals age (Bermingham-
McDonogh et al., 2006). Although Yamamoto et al. reported
that adult supporting cells could differentiate into hair cells
even at the postnatal stage by inhibiting Notch signaling
(Yamamoto et al., 2006), the efficiency was too low to
regenerate hair cells. It is necessary to investigate how
postnatal supporting cells can differentiate into hair cells by
177S. Takebayashi et al. / Developmental Biology 307 (2007) 165–178Notch inhibition efficiently and whether progenitor cells,
which supposedly exist in the pillar cell area, can proliferate
by Notch signaling inhibition.
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